[A2k] Infojustice Roundup - September 22, 2014

Michael Palmedo mpalmedo at wcl.american.edu
Mon Sep 22 12:08:30 PDT 2014


Infojustice Roundup  

 

Sep 24: Plain Packaging for the Pacific Rim - The Trans-Pacific
Partnership and Tobacco Control

 

[PIJIP] This week, Australia National University Professor Matthew
Rimmer will speak at American University.  Dr. Rimmer argues that Big
Tobacco has been engaged in a dark, shadowy plot and conspiracy to
hijack the Trans-Pacific Partnership Agreement (TPP) and undermine
tobacco control measures - such as graphic health warnings and the plain
packaging of tobacco products. The event is free and open to the public,
and will be webcast.  Click here for more.
<http://infojustice.org/archives/33278> 

 

Gilead's Hepatitis C Medicines License - Troubling Territorial
Exclusions, Illusory Exceptions, and Tiered Pricing Policy Fracture
Global Access

 

[Brook Baker] Gilead has just released the text of its hepatitis C
license.  Although there has been some praise for Gilead offering
expanded generic access in 91 countries where over 100 million people
living with hepatitis C live, there has also been mounting criticism
over its exclusion of 51 middle-income countries with 49 million
infected. This paper closely analyzes the license to see what its impact
might be, paying close attention to its definition of covered patent
rights and illusory mechanisms that might eventually allow supply in
some excluded territories.  Click here for more.

 

See also:

*         International Treatment Preparedness Coalition. A Step Back
for Millions of People with Hepatitis C. (Link
<http://www.itpcglobal.org/resource?id=urn:uuid:c147a3ed-a8f2-4754-8835-
29a35372de75> )

*         Statement by the Malaysian Treatment Access and Advocacy Group
(MTAAG) and the Third World Network. (Link
<http://lists.keionline.org/pipermail/ip-health_lists.keionline.org/2014
-September/004347.html> )

*         MSF Access Campaign Response to Gilead's Deal with Generic
Companies for Sofosbuvir and Ledipasvir.  (Link
<http://www.msfaccess.org/content/msf-access-campaign-response-gilead%E2
%80%99s-deal-generic-companies-sofosbuvir-and-ledipasvir> )

*         James Love, KEI. The Gilead HCV license: Glass half empty, or
half full? (Link <http://keionline.org/node/2083> )

 

Pharmaceutical CEO: This Controversial Deal Will Be Great for Us...And
You

 

[Steven Knievel] In an op-ed appearing in Forbes on Tuesday, the CEO of
Eli Lilly, a U.S. pharmaceutical corporation, paints a glowing picture
of how the proposed Trans-Atlantic Free Trade Agreement (TAFTA) would
benefit consumers on both sides of the Atlantic - but it's pure fantasy.
It is not surprising that Eli Lilly is cheerleading this controversial
deal. This is the same pharmaceutical firm that is using the North
American Free Trade Agreement (NAFTA) - TAFTA's predecessor - to
challenge Canada's legal standards for granting patents and demand $500
million in taxpayer compensation. Click here for more.
<http://infojustice.org/archives/33285> 

 

New State-Level Policy Brief on Open Educational Resources

 

[Nicole Allen]  A new briefing paper on state-level open educational
resources policy was released yesterday by the Education Commission of
the States (ECS), a non-partisan think tank that provides education
policy advice to U.S. states. Entitled "Open source textbooks can help
drive down the overall cost of college," the brief provides an overview
of trends in OER policy to address the rising cost of college textbooks.
Click here for more. <http://infojustice.org/archives/33294> 

 

WIPO Assemblies: Heavy Agenda With Potential Decisions On Normative
Agenda

 

[Catherine Saez] The Assemblies of the World Intellectual Property
Organisation member states opened this morning in a new conference hall
for a 10-day marathon with many decisions to be taken on the programme
of work of the organisation for the year to come, its governance, and
the need to address issues left opened by several committees. WIPO
Director General Francis Gurry opened the week by highlighting the
successes of the organisation while underlining the challenges in the
normative agenda. He mentioned platforms of cooperation developed by
WIPO as a parallel track presenting opportunities for advancing
international cooperation. The 54th Assemblies of the Member States of
WIPO is taking place from 22-30 September. Click here for the full story
on IP Watch.
<http://www.ip-watch.org/2014/09/22/wipo-assemblies-heavy-agenda-with-po
tential-decisions-on-normative-agenda/> 

 

Demystifying the Role of Copyright as a Tool for Economic Development in
Africa: Tackling the Harsh Effects of the Transferability Principle in
Copyright Law

 

[Joel J Baloyi] Abstract: ... It is argued, however, that the
transferability principle has had the inadvertent effect of stifling
copyright-based entrepreneurship, and thus economic development in these
countries. Because of the conditions of impoverishment prevailing in
these countries, authors find that they do not have the material
resources to economically exploit their copyright works. They thus have
no option but to assign their copyrights to others, mainly foreign
entities, resulting in an endless cycle where they can never act
entrepreneurially in respect of their copyrights. The paper seeks to
explore this phenomenon and make proposals of possible solutions. Click
here for the full paper on SSRN.
<http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2497850> 

 




More information about the A2k mailing list